Technological-based Personalized Care Intervention for Supporting Older People With Diabetes Mellitus
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- The point of care test (POCT) of HbA1C level
研究概览
简要总结
The objectives of this project are (1) to develop a new model of DM management using non-invasive healthcare technology for continuous glucose monitoring; (2) to use health apps to give timely personalized care intervention for enhancing compliance rate of DM self-management; & (3) to compare the DM management using non-invasive healthcare technology to traditional invasive blood glucose monitoring method.
The proposed study will adopt a RCT with two treatment arms to clarify the effects of non-invasive blood glucose device on blood glucose monitoring. The two arms will be the non-invasive blood glucose monitoring (arm 1) and traditional self-monitoring (arm 2) as a control. A block randomisation and a single-blind design will be used. The inclusion criteria are (1) aged ≥ 60 years old; (2) patients diagnosed with Type II DM; (3) patients experienced hypo (histix < 4.0 mmol/L) or hyperglycemia (histix ≥16.0 mmol/L); & (iv) the Abbreviated Mental Test (AMT) ≥ 6.
Participants fitting the inclusion criteria will be selected by convenience sampling. They will join a two-arm RCT and will be allocated into the intervention or control group in a 1:1 ratio.
The primary outcomes will be the point of care test (POCT) of HbA1C level and the secondary outcomes will be the fasting blood glucose, total cholesterol, blood pressure, basic anthropometric measurement, breath and blood ketone and Diabetes Self-Care activities questionnaire. The outcome measurements will be recorded before the intervention (T0) and immediately after the 8-week intervention (T1).
The required sample size would be 30 participants per group (with a ratio of 1:1) for testing the feasibility of the study.
详细描述
Research aim
1. This study will aim to develop a new model of DM management using non- invasive healthcare technology for continuous glucose monitoring.
2 To use health apps to give timely personalized care intervention for enhancing compliance rate of DM self-management. 3. To compare the DM management using non-invasive healthcare technology to traditional invasive blood glucose monitoring method. 4. To improve self-management skills, decrease hospital admissions, and save medical.
Our DM project integrates personalized care intervention with a non-invasive continuous glucose monitoring (CGM) device for diabetes patients. The use of mHealth (Mobile health) ensures timely care without time or location constraints, while Just-in-Time Adaptive Intervention (JITAI) provides instant, personalized support. The painless, non-invasive CGM device offers an alternative to traditional finger-prick methods, improving compliance with self-management. This approach is particularly beneficial for patients who struggle with conventional monitoring and aims to enhance both patient outcomes and healthcare efficiency, especially for older people at high risk of hypo- or hyperglycemia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •aged ≥ 60 years old;
- •patients diagnosed with Type II DM without insulin injections;
- •patients experienced hypo (histix < 4.0 mmol/L) or hyperglycemia (histix
- •16.0 mmol/L); &
- •2. The Abbreviated Mental Test (AMT) ≥ 6.
排除标准
- •patient on dialysis;
- •taking ascorbic acid > 500mg daily or (Not recommended by manufacturer as result may be affected);
- •taking salicylic acid ≥ 650mg single dose or (Not recommended by manufacturer as result may be affected); or
- •scheduled radiological therapy during CGM application (Not recommended by manufacturer as result may be affected).
研究组 & 干预措施
Non invasive blood glucose monitoring group
Non invasive blood glucose monitoring : Participants will use a non-invasive sensor on the arm for blood glucose monitoring during the first and second weeks, as well as the seventh and eighth weeks. Between the third and sixth weeks, participants will be asked to monitor their blood glucose levels at home using traditional methods.
干预措施: Non-invasive blood glucose monitoring (Behavioral)
Traditional blood glucose monitoring
Traditional blood glucose monitoring : Participants will engage in traditional self-monitoring of blood glucose at home over the course of 8 weeks. They are recommended to check their blood glucose levels one to two times per week and record all results. This will allow for the collection of data using traditional monitoring methods.
干预措施: Traditional blood glucose monitoring (Behavioral)
结局指标
主要结局
The point of care test (POCT) of HbA1C level
时间窗: 8 weeks
Change in HbA1C level The HbA1C will be measured by A1CNow system.
次要结局
- Change in lipid and glucose panel(8 weeks)
- Change in basic anthropometric measurement(8 weeks)
- Change in blood pressure(8 weeks)
- Change in breath and blood ketone(8 weeks)
- Change in Summary of Diabetes Self-Care Activities (SDSCA) Chinese Version(8 weeks)
研究者
Dr Queenie Law Pui Sze
Associate Professor
Hong Kong Metropolitan University